Clinical Trials Browser

INDUSTRY × cabozantinib × Tumor-Agnostic × Clear all

NCT03768063 2026-01-29

IMbrella B

Phase 3 Active not recruiting

Neoplasms

NCT01553656 2015-08-20

Dose-Finding Study of Cabozantinib (XL184) in Japanese Subjects With Advanced Cancer

Phase 1 Completed

Neoplasm Metastasis, Neoplasms

NCT01018745 2011-01-07

Multiple Ascending Dose Study of BMS-907351 (XL184) in Patients With Solid Tumors in Japan

Phase 1 Completed

Neoplasms